Physical examination may reveal an irregular pulse, variable heart rate, or signs of heart failure
Based on FLOW, FDA approved Ozempic for the reduction of worsening kidney disease, kidney failure, and CV death in T2D + CKD patients on January 28, 2025 expanding the testing and biomarker monitoring requirements for Ozempic to include kidney function endpoints
It's the primary reason Zepbound's efficacy profile is considerably stronger than Saxenda's
When we look at peoples total fruit or vegetable consumption, or at other individual fruits such as apples or bananas, we dont see any relationship between intake and risk of depression. Last but not least, exercise continues to emerge as an important factor in protecting brain and mental health
Endocrinology 143 , 24202426 (2002)
a specific transition protocol is needed to avoid side effects